News | January 28, 2014

BioLeonhardt Unveils Stem Cell Pump??

First implantable pump for timed dosed repeat delivery of stem cells and growth factors

BioLeonhardt Implantable Stem Cell Pump Cath Lab Therapies Heart Failure
January 28, 2014 — BioLeonhardt, a Leonhardt Ventures company based in Los Angeles, unveiled its implantable stem cell pump at the 9th Annual Cell Therapy for Cardiovascular Disease meeting at Columbia University, Jan. 23, 2014.
 
BioLeonhardt’s programmable implantable stem cell infusion pump and electrical stimulator combine to treat advanced heart failure. The stem cell pump is implanted in the patient's abdomen and has a silicone septum to allow re-loading via a micro needle syringe of stem cells, genes, growth factors and nutrient hydrogels.  The pump is attached to a combination coaxial reinforced infusion catheter and electrical conduction lead, which has its tip anchored into the patient's damaged heart tissue.  
 
BioLeonhardt's proposed method to treating heart failure:
1.  Pre-Treat Scar - Micro-RNAs, Nutrient Hydrogel, Growth Factors, Electrical Stimulation, GCSF, endothelial progenitor cells and adipose derived cells.
2.  Treat Scar - Muscle derived cardiac progenitor cells in center of scar, cardiac stem cells or iPS cells at rim edge of scar, temporary implantable circulatory assist pump to allow heart to rest. 
3.  Post Implantation Scar Maintenance - Repeat injections/infusions + electrical stimulation. 
 
The method utilizes BioLeonhardt’s programmable pump to repeat dosing, and will be tested in a controlled study for heart failture. 
 
BioLeonhardt has granted an exclusive license for myoblast transplantation with their pump to another Leonhardt founded company, Bioheart Inc. Myoblast traplantation has been in clinical trials utilizing selected immature myoblasts to treat heart failure since early 2001. Over 400 patients have been enrolled in various myoblast trials worldwide and 84 percent have improved in at least one parameter. 
 
For more information: bioleonhardt.com

Related Content

Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Recent Acquisitions Eroding Prices in Billion Dollar European Interventional Cardiology cath lab Market.
Feature | Cath Lab | May 07, 2018 | Simon Trinh and Jeffrey Wong
The European interventional cardiology market is currently valued at nearly $1.4 billion.
Videos | Cath Lab | May 07, 2018
Imran Ahmad, M.D., medical director of interventional cardiology, explains some of the new technologies his labs have
360 Photos | Cath Lab | April 20, 2018
A 360 degree view of the newest cath lab at Northwestern Medicine Central DuPage Hospital in Winfield, Ill., located
SCAI Announces Global Lecture Series for 2018 Scientific Sessions
News | Cath Lab | April 18, 2018
Many of the world’s leading interventional cardiologists and cardiovascular professionals will convene in San Diego,...
Overlay Init